Abstract
Doxorubicin is a chemotherapy drug used to treat several types of cancer, with high effectiveness; however, its toxicity in several organs may limit clinical use. Peripheral muscles toxicity is multifactorial and not well stablished, but doxorubicin appears to alter muscle energy metabolism, leading to increased anaerobic metabolism and muscle atrophy. Muscle mass loss is a prognostic mar…